ResMed, Inc. (RMD)

246.58 -0.76 (-0.31%) USD  |  NYSE  |  Dec 17, 15:45
More

ResMed Research and Development Expense (Annual): 331.28M for June 30, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Abbott Laboratories 2.823B
Boston Scientific Corp. 1.615B
Becton, Dickinson & Co. 1.265B
Stryker Corp. 1.414B
West Pharmaceutical Services, Inc. 69.10M